Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial by Hida, Toyoaki, MD, Nokihara, Hiroshi, MD, Kondo, Masashi, MD, Kim, Young Hak, MD, Azuma, Koichi, MD, Seto, Takashi, MD, Takiguchi, Yuichi, Prof, Nishio, Makoto, MD, Yoshioka, Hiroshige, MD, Imamura, Fumio, MD, Hotta, Katsuyuki, Prof, Watanabe, Satoshi, MD, Goto, Koichi, MD, Satouchi, Miyako, MD, Kozuki, Toshiyuki, MD, Shukuya, Takehito, MD, Nakagawa, Kazuhiko, Prof, Mitsudomi, Tetsuya, Prof, Yamamoto, Nobuyuki, Prof, Asakawa, Takashi, PhD, Asabe, Ryoichi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr

Get full text

Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG060... by Goto, Koichi, Dr, Ohe, Yuichiro, MD, Shibata, Taro, MSc, Seto, Takashi, MD, Takahashi, Toshiaki, MD, Nakagawa, Kazuhiko, Prof, Tanaka, Hiroshi, MD, Takeda, Koji, MD, Nishio, Makoto, MD, Mori, Kiyoshi, MD, Satouchi, Miyako, MD, Hida, Toyoaki, MD, Yoshimura, Naruo, MD, Kozuki, Toshiyuki, MD, Imamura, Fumio, MD, Kiura, Katsuyuki, Prof, Okamoto, Hiroaki, MD, Sawa, Toshiyuki, MD, Tamura, Tomohide, MD

Get full text

Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyper... by Kubota, Kaoru, Prof, Hida, Toyoaki, MD, Ishikura, Satoshi, MD, Mizusawa, Junki, MSc, Nishio, Makoto, MD, Kawahara, Masaaki, MD, Yokoyama, Akira, MD, Imamura, Fumio, MD, Takeda, Koji, MD, Negoro, Shunichi, MD, Harada, Masao, MD, Okamoto, Hiroaki, MD, Yamamoto, Nobuyuki, MD, Shinkai, Tetsu, MD, Sakai, Hiroshi, MD, Matsui, Kaoru, MD, Nakagawa, Kazuhiko, Prof, Shibata, Taro, MSc, Saijo, Nagahiro, Prof, Tamura, Tomohide, MD

Get full text

Manual route modification using an oblique method following automatic virtual bronchoscopic navigation by Inoue, Takako, Kawamura, Takahisa, Kunimasa, Kei, Tamiya, Motohiro, Kuhara, Hanako, Nishino, Kazumi, Odani, Satomi, Imamura, Fumio, Kumagai, Toru, Miyake, Kotaro

Get full text

Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib by Kunimasa, Kei, Kamada, Risa, Oka, Toru, Oboshi, Makiko, Kimura, Madoka, Inoue, Takako, Tamiya, Motohiro, Nishikawa, Tatsuya, Yasui, Taku, Shioyama, Wataru, Nishino, Kazumi, Imamura, Fumio, Kumagai, Toru, Fujita, Masashi

Get full text

RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With EGFR-Mutated Metastatic NSCLC by Nishio, Makoto, Nishio, Kazuto, Reck, Martin, Garon, Edward B., Imamura, Fumio, Kawaguchi, Tomoya, Yamaguchi, Hiroyuki, Ikeda, Satoshi, Hirano, Katsuya, Visseren-Grul, Carla, Ceccarelli, Matteo, Wijayawardana, Sameera R., Zimmermann, Annamaria, Matsui, Tomoko, Enatsu, Sotaro, Nakagawa, Kazuhiko

Get full text